RW Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$678K Sell
1,872
-55
-3% -$18.8K 0.06% 62
2026
Q1
$678K Buy
+1,927
New +$687K 0.07% 59
2025
Q3
$544K Sell
1,927
-12
-0.6% -$3.48K 0.06% 62
2025
Q2
$541K Buy
1,939
+12
+0.6% +$3.4K 0.06% 59
2025
Q1
$600K Sell
1,927
-120
-6% -$35.4K 0.07% 50
2024
Q4
$534K Hold
2,047
0.07% 59
2024
Q3
$660K Hold
2,047
0.08% 53
2024
Q2
$640K Hold
2,047
0.09% 53
2024
Q1
$582K Sell
2,047
-113
-5% -$33.1K 0.08% 54
2023
Q4
$622K Sell
2,160
-113
-5% -$30.8K 0.09% 49
2023
Q3
$611K Hold
2,273
0.11% 44
2023
Q2
$505K Hold
2,273
0.1% 50
2023
Q1
$549K Hold
2,273
0.15% 44
2022
Q4
$597K Buy
+2,273
New +$609K 0.23% 41

Other funds holding AMGN

RW Investment Management's AMGN Position: Q2 2026 in Review

RW Investment Management reduced its Amgen (AMGN) stake by 2.9% in Q2 2026, selling an estimated $18.8K and leaving 1,872 shares worth $678K. The position accounts for 0.06% of the portfolio, ranked #62.

RW Investment Management first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $678K in Q1 2026. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • RW Investment Management held 1,872 shares of Amgen worth $678K as of Q2 2026.
  • RW Investment Management sold 55 Amgen shares in Q2 2026, an estimated $18.8K.
  • Amgen made up 0.06% of RW Investment Management's portfolio in Q2 2026, its #62 holding.
  • RW Investment Management first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • RW Investment Management's Amgen position peaked at $678K in Q1 2026.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on RW Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.